ASCO Genitourinary Cancers Symposium
Playback speed
10 seconds
ASCO GU 2022 OS in mHSPC Treated With Enzalutamide + ADT by High/Low Disease Volume and Progression to (de Novo) mHSPC (M0/M1 at Diagnosis): Post Hoc Analysis of the Phase 3 ARCHES Trial
By
ASCO Genitourinary Cancers Symposium
FEATURING
Andrew Armstrong
By
ASCO Genitourinary Cancers Symposium
FEATURING
Andrew Armstrong
53 views
March 2, 2022
Login to view comments.
Click here to Login
Videos